The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The chronic wound milieu changes essential oils' antibiofilm activity—an in vitro and larval model study
Abstract
Essential Oils (EOs) are currently being researched as potential antibiofilm agents to combat infections related to chronic wound biofilms. As documented in the literature, EOs’ in vitro antibacterial properties are often assessed using standard microbiological media and conditions that do not accurately reflect the actual environment of a chronic wound. To address this issue, In vitro Wound Milieu (IVWM) medium, which closely resembles the environment of a chronic wound, was applied for culturing S. aureus biofilms (n = 12) in this research. Biofilms cultivated in the standard Tryptic Soy Broth (TSB) medium served as a control for the experiment. Key biofilm features were analyzed and compared. Subsequently, staphylococci were exposed to the activity of thyme or rosemary EOs (T-EO and R-EO, respectively). As proof of concept, the cytotoxicity of T-EO and its antimicrobial in vivo activity were assessed using a G. mellonella larvae model. Key features of biofilm-forming cells were lower in the IVWM than in the TSB medium: biomass (up to 8 times), metabolic activity (up to 9 times), cell number (up to 100 times), and the live/dead cells ratio. Conversely, biofilm thickness was higher (up to 25%) in IVWM. These differences translated into varied responses of the biofilms to EOs exposure. The application of T-EO led to a greater reduction (up to 2 times) in 67% of biofilm-forming strains in IVWM compared to the TSB medium. Conversely, exposure to R-EO resulted in a higher reduction (up to 2.6 times) of 83% of biofilm-forming strains in TSB than in IVWM. The application of T-EO was not only non-toxic to G. mellonella larvae but also increased the survival of larvae infected with staphylococci (from 48 to 85%). Our findings suggest that EOs not only show promise as agents for treating biofilm-related wound infections but also that providing conditions reflecting the specific niche of the human body is of paramount importance in influencing the results obtained. However, before clinical application, challenges related to the methods of assessing their activity, microbial intra-species variability, and different levels of activity of various EOs should be analyzed and standardized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with previous reports, thyme oils were the most effective at low dilutions (Brożyna et al. 2024; Fournomiti et al. 2015; Sakkas and Papadopoulou 2017).”
From Linking chemical-composition to antimicrobial efficacy: development of an essential oil-based topical gel prototype (2025) · cites this paper as Brożyna et al. 2024
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Armstrong, D. G., Swerdlow, M. A., Armstrong, A. A., Conte, M. S., Padula, W. V., & Bus, S. A. (2020) · Journal of Foot and Ankle Research · doi:10.1186/s13047-020-00383-2 · Cited by 975
Essential Oils, A New Horizon in Combating Bacterial Antibiotic Resistance
Yap, P. S. X., Yiap, B. C., Ping, H. C., & Lim, S. H. E. (2014) · The Open Microbiology Journal · doi:10.2174/1874285801408010006 · Cited by 426
Research works printed but not linked: 46
- Mühlen, S. & Dersch, P. Anti-virulence strategies to target bacterial infections. Curr. Top. Microbiol. Immunol. 398, 147–183 (2016).
- Bowler, P. G. Antibiotic resistance and biofilm tolerance: A combined threat in the treatment of chronic infections. J. Wound Care 27, 273–277 (2018). · DOI
- Leaper, D., Assadian, O. & Edmiston, C. E. Approach to chronic wound infections. Brit. J. Dermatol. 173, 351–358 (2015). · DOI · Paper page
- Percival, S. L., Emanuel, C., Cutting, K. F. & Williams, D. W. Microbiology of the skin and the role of biofilms in infection. Int. Wound. J. 9, 14–32 (2012). · DOI · Paper page
- Povolotsky, T. L., Keren-Paz, A. & Kolodkin-Gal, I. Metabolic microenvironments drive microbial differentiation and antibiotic resistance. Trends Genet. 37, 4–8 (2021). · DOI
- Kaiser, P., Wächter, J. & Windbergs, M. Therapy of infected wounds: overcoming clinical challenges by advanced drug delivery systems. Drug Deliv. Transl. Res. 11, 1545–1567 (2021). · DOI
- Siddiqui, A. R. & Bernstein, J. M. Chronic wound infection: Facts and controversies. Clin. Dermatol. 28, 519–526 (2010). · DOI · Paper page
- Alves, P. J. et al. Update on the role of antiseptics in the management of chronic wounds with critical colonisation and/or biofilm. Int. Wound J. 18, 342–358 (2021). · DOI
- Becker, S. L. et al. Outbreak of Burkholderia cepacia complex infections associated with contaminated octenidine mouthwash solution, Germany, August to September 2018. Eurosurveillance 23, 180050 (2018). · doi:10.2807/1560-7917.es.2018.23.42.1800540
- Shepherd, M. J., Moore, G., Wand, M. E., Sutton, J. M. & Bock, L. J. Pseudomonas aeruginosa adapts to octenidine in the laboratory and a simulated clinical setting, leading to increased tolerance to chlorhexidine and other biocides. J. Hosp. Infect. 100, e23–e29 (2018). · DOI
- Silva, N. B. S., Marques, L. de A. & Röder, D. von D. de B. Antibiofilm activity of natural products: Promising strategies for combating microbial biofilms. Ann. Public Health Rep. 4, 92–99 (2020) · DOI
- Agreles, M. A. A., Cavalcanti, I. D. L. & Cavalcanti, I. M. F. The role of essential oils in the inhibition of efflux pumps and reversion of bacterial resistance to antimicrobials. Curr. Microbiol. 78, 3609–3619. https://doi.org/10.1007/s00284-021-02635-1 (2021). · DOI
- Reichling, J. Anti-biofilm and virulence factor-reducing activities of essential oils and oil components as a possible option for bacterial infection control. Planta Med. 86, 520–537 (2020). · DOI
- Costa, M. F., Durço, A. O., Rabelo, T. K., Barreto, R. D. S. S. & Guimarães, A. G. Effects of Carvacrol, Thymol and essential oils containing such monoterpenes on wound healing: a systematic review. J. Pharm. Pharmacol. 71(2), 141–155 (2019). · DOI
- Sienkiewicz, M. et al. The ability of selected plant essential oils to enhance the action of recommended antibiotics against pathogenic wound bacteria. Burns 43, 310–317 (2017). · DOI
- Orchard, A., Sandasi, M., Kamatou, G., Viljoen, A. & van Vuuren, S. The in vitro antimicrobial activity and chemometric modelling of 59 commercial essential oils against pathogens of dermatological relevance. Chem. Biodivers. 14, 1600218 (2017). · DOI
- Patterson, J. E., McElmeel, L. & Wiederhold, N. P. In vitro activity of essential oils against Gram-positive and Gram-negative clinical isolates, including carbapenem-resistant Enterobacteriaceae. Open Forum Infect. Dis. 6, 496339 (2019). · DOI
- Vyas, H. K. N., Xia, B. & Mai-Prochnow, A. Clinically relevant in vitro biofilm models: A need to mimic and recapitulate the host environment. Biofilm 4, 100069 (2022). · DOI
- Thaarup, I. C. & Bjarnsholt, T. Current in vitro biofilm-infected chronic wound models for developing new treatment possibilities. Adv. Wound Care New Rochelle 10, 91–102 (2021). · DOI
- Kadam, S. et al. Milieu matters: An in vitro wound milieu to recapitulate key features of, and probe new insights into, mixed-species bacterial biofilms. Biofilm 3, 100047 (2021). · DOI
- Kowalczyk, A., Przychodna, M., Sopata, S., Bodalska, A. & Fecka, I. Thymol and thyme essential oil—New insights into selected therapeutic applications. Molecules 25, 84125. https://doi.org/10.3390/molecules25184125 (2020). · DOI · Paper page
- Melkina, O. E., Plyuta, V. A., Khmel, I. A. & Zavilgelsky, G. B. The mode of action of cyclic monoterpenes (−)-limoneneand (+)-α-pinene on bacterial cells. Biomolecules 11, 806 (2021). · doi:10.3390/biom11060806
- Aguila, A. et al. Bacteriostatic activity of human lactoferrin against Staphylococcus aureus is a function of its iron-binding properties and is not influenced by antibiotic resistance. FEMS Immunol. Med. Microbiol. 31, 145–152 (2001). · DOI
- Ammons, M. C. & Copié, V. Mini-review: Lactoferrin: A bioinspired, anti-biofilm therapeutic. Biofouling 29, 443–455 (2013). · DOI
- Roseanu, A., Damian, M. & Evans, R. W. Mechanisms of the antibacterial activity of lactoferrin and lactoferrin-derived peptides. Rom. J. Biochem. 47, 203–209 (2010).
- Abraham, N. M. & Jefferson, K. K. A low molecular weight component of serum inhibits biofilm formation in Staphylococcus aureus. Microb. Pathog. 49, 388–391 (2010). · DOI
- Fazli, M. et al. Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J. Clin. Microbiol. 47, 4084–4089 (2009). · DOI · Paper page
- Kirketerp-Møller, K. et al. Distribution, organization, and ecology of bacteria in chronic wounds. J. Clin. Microbiol. 46, 2717–2722 (2008). · DOI · Paper page
- Bay, L. et al. Bacterial aggregates establish at the edges of acute epidermal wounds. Adv. Wound Care New Rochelle 7, 105–113 (2018). · DOI
- Crosby, H. A., Kwiecinski, J. & Horswill, A. R. Staphylococcus aureus aggregation and coagulation mechanisms, and their function in host-pathogen interactions. Adv. Appl. Microbiol. 96, 1–41 (2016). · DOI
- Pestrak, M. J. et al. Investigation of synovial fluid induced Staphylococcus aureus aggregate development and its impact on surface attachment and biofilm formation. PLoS One 15, e0233534 (2020). · DOI
- Marcos-Zambrano, L. J., Escribano, P., Bouza, E. & Guinea, J. Production of biofilm by Candida and non-Candida spp. isolates causing fungemia: Comparison of biomass production and metabolic activity and development of cut-off points. Int. J. Med. Microbiol. 304, 1192–1198 (2014). · DOI · Paper page
- Xu, Z. et al. Crystal violet and XTT assays on Staphylococcus aureus biofilm quantification. Curr. Microbiol. 73, 474–482 (2016). · DOI · Paper page
- Chambless, J. D., Hunt, S. M. & Stewart, P. S. A three-dimensional computer model of four hypothetical mechanisms protecting biofilms from antimicrobials. Appl. Environ. Microbiol. 72, 2005–2013 (2006). · DOI · Paper page
- Mutlu-Ingok, A., Firtin, B., Karbancioglu-Guler, F. & Altay, F. A study on correlations between antimicrobial effects and diffusion coefficient, zeta potential and droplet size of essential oils. Int. J. Food Eng. 16, 20190354 (2020). · DOI
- Stiefel, P. et al. Is biofilm removal properly assessed? Comparison of different quantification methods in a 96-well plate system. Appl. Microbiol. Biotechnol. 100, 4135–4145 (2016). · DOI
- Brożyna, M. et al. The antimicrobial and antibiofilm in vitro activity of liquid and vapour phases of selected essential oils against Staphylococcus aureus. Pathogens 10, 1207 (2021). · DOI
- Kot, B., Wierzchowska, K., Grużewska, A. & Lohinau, D. The effects of selected phytochemicals on biofilm formed by five methicillin-resistant Staphylococcus aureus. Nat. Prod. Res. 32, 1299–1302 (2018). · DOI
- Tohidpour, A., Sattari, M., Omidbaigi, R., Yadegar, A. & Nazemi, J. Antibacterial effect of essential oils from two medicinal plants against Methicillin-resistant Staphylococcus aureus (MRSA). Phytomedicine 17, 142–145 (2010). · DOI · Paper page
- Hammer, K. A. & Carson, C. F. Antibacterial and antifungal activities of essential oils. in Lipids and Essential Oils as Antimicrobial Agents 255–306 (John Wiley and Sons, Ltd, 2010). doi:https://doi.org/10.1002/9780470976623.ch11. · DOI
- Juven, B. J., Kanner, J., Schved, F. & Weisslowicz, H. Factors that interact with the antibacterial action of thyme essential oil and its active constituents. J. Appl. Bacteriol. 76, 626–631 (1994). · DOI · Paper page
- Veldhuizen, E. J. A., Creutzberg, T. O., Burt, S. A. & Haagsman, H. P. Low temperature and binding to food components inhibit the antibacterial activity of carvacrol against Listeria monocytogenes in steak tartare. J. Food Prot. 70, 2127–2132 (2007). · DOI
- Paleczny, J. et al. The high impact of Staphylococcus aureus biofilm culture medium on in vitro outcomes of antimicrobial activity of wound antiseptics and antibiotic. Pathogens 10, 1385 (2021). · DOI
- Paleczny, J. et al. The medium composition impacts Staphylococcus aureus biofilm formation and susceptibility to antibiotics applied in the treatment of bone infections. Int. J. Mol. Sci. 23, 764662 (2022). · DOI
- Brożyna, M. et al. Chemical composition and antibacterial activity of liquid and volatile phase of essential oils against planktonic and biofilm-forming cells of Pseudomonas aeruginosa. Molecules 27, 6354696 (2022). · DOI
- Krasowski, G. et al. The assessment of activity of antiseptic agents against biofilm of Staphylococcus aureus measured with the use of processed microscopic images. Int. J. Mol. Sci. 23, 4663 (2022). · DOI
Cited by
Aftab, N., Varghese, P., Khalid, A., Umar, A. K., Wallis, C. J., Bates, M., & Hooper, S. E. (2025) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-025-13650-8 · Cited by 2
Metadata
- Authors
- Brożyna, M., Dudek, B., Kozłowska, W., Malec, K., Paleczny, J., Detyna, J., Fabianowska-Majewska, K., & Junka, A.
- Venue
- Scientific Reports
- Published
- 2024-01-26
- Volume
- 14
- Issue
- 1
- ISSN
- 2045-2322
- Cited by
- 24
- References
- 2
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- Narodowe Centrum Nauki (2021/41/N/NZ6/03305)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The chronic wound milieu changes essential oils' antibiofilm activity—an in vitro and larval model study. https://app.cochat.ai/papers/10.1038/s41598-024-52424-6
- The paper
- Brożyna, M., Dudek, B., Kozłowska, W., Malec, K., Paleczny, J., Detyna, J., Fabianowska-Majewska, K., & Junka, A. (2024). The chronic wound milieu changes essential oils' antibiofilm activity—an in vitro and larval model study. Scientific Reports. https://doi.org/10.1038/s41598-024-52424-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.